Marton König

11PUBLICATIONS
20CO-AUTHORS
Nanotoxicology, health and safetyPeripheral nervous systemPredictive and prognostic markersInnate immunityRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 25, 2026
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab.

Einar August Høgestøl, Åge Winje Brustad, Elisabeth Gulowsen Celius

|Mar 16, 2026
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

Tilde Harridsleff Rasmussen, Stine Schikora-Rustad, Åslaug Rudjord Lorentzen

|Oct 21, 2021
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations.

Marton König, Åslaug Rudjord Lorentzen, Hilde Marie Torgauten

|Jun 02, 2021
STA-MCA Bypass in Carotid Stenosis after Radiosurgery for Cavernous Sinus Meningioma.

Marco Vincenzo Corniola, Marton König, Torstein Ragnar Meling

|Dec 31, 2020
Squamous Cell Carcinoma of the Paranasal Sinuses: A Single Center Experience.

Marton König, Terje Osnes, Åse Bratland

Pageof 2